-
1
-
-
0028353674
-
Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations
-
Byrne MM, Sturis J, Cl ément K, et al. Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations. J Clin Invest 1994;93:1120-1130
-
(1994)
J Clin Invest
, vol.93
, pp. 1120-1130
-
-
Byrne, M.M.1
Sturis, J.2
Clément, K.3
-
2
-
-
84865499896
-
Antenatal diagnosis of fetal genotype determines if maternal hyperglycemia due to a glucokinase mutation requires treatment
-
Chakera AJ, Carleton VL, Ellard S, et al. Antenatal diagnosis of fetal genotype determines if maternal hyperglycemia due to a glucokinase mutation requires treatment. Diabetes Care 2012;35:1832-1834
-
(2012)
Diabetes Care
, vol.35
, pp. 1832-1834
-
-
Chakera, A.J.1
Carleton, V.L.2
Ellard, S.3
-
3
-
-
58149216624
-
Pregnancy outcome in patients with raised blood glucose due to a heterozygous glucokinase gene mutation
-
Spyer G, Macleod KM, Shepherd M, Ellard S, Hattersley AT. Pregnancy outcome in patients with raised blood glucose due to a heterozygous glucokinase gene mutation. Diabet Med 2009;26: 14-18
-
(2009)
Diabet Med
, vol.26
, pp. 14-18
-
-
Spyer, G.1
Macleod, K.M.2
Shepherd, M.3
Ellard, S.4
Hattersley, A.T.5
-
4
-
-
84899074567
-
The 0.1% of the population with glucokinase monogenic diabetes can be recognized by clinical characteristics in pregnancy: The Atlantic Diabetes in Pregnancy cohort
-
Chakera AJ, Spyer G, Vincent N, Ellard S, Hattersley AT, Dunne FP. The 0.1% of the population with glucokinase monogenic diabetes can be recognized by clinical characteristics in pregnancy: The Atlantic Diabetes in Pregnancy cohort. Diabetes Care 2014;37:1230-1236
-
(2014)
Diabetes Care
, vol.37
, pp. 1230-1236
-
-
Chakera, A.J.1
Spyer, G.2
Vincent, N.3
Ellard, S.4
Hattersley, A.T.5
Dunne, F.P.6
-
5
-
-
84890900649
-
Crosssectional and longitudinal studies suggest pharmacological treatment used in patients with glucokinase mutations does not alter glycaemia
-
Stride A, Shields B, Gill-Carey O, et al. Crosssectional and longitudinal studies suggest pharmacological treatment used in patients with glucokinase mutations does not alter glycaemia. Diabetologia 2014;57:54-56
-
(2014)
Diabetologia
, vol.57
, pp. 54-56
-
-
Stride, A.1
Shields, B.2
Gill-Carey, O.3
-
6
-
-
84892649702
-
Prevalence of vascular complications among patients with glucokinase mutations and prolonged, mild hyperglycemia
-
Steele AM, Shields BM, Wensley KJ, Colclough K, Ellard S, Hattersley AT. Prevalence of vascular complications among patients with glucokinase mutations and prolonged, mild hyperglycemia. JAMA 2014;311:279-286
-
(2014)
JAMA
, vol.311
, pp. 279-286
-
-
Steele, A.M.1
Shields, B.M.2
Wensley, K.J.3
Colclough, K.4
Ellard, S.5
Hattersley, A.T.6
-
7
-
-
41149139275
-
Best practice guidelines for themolecular genetic diagnosis of maturity-onset diabetes of the young
-
European MolecularGeneticsQualityNetwork (EMQN) MODY group
-
Ellard S, Bellanné-Chantelot C, Hattersley AT; European MolecularGeneticsQualityNetwork (EMQN) MODY group. Best practice guidelines for themolecular genetic diagnosis of maturity-onset diabetes of the young. Diabetologia 2008;51:546-553
-
(2008)
Diabetologia
, vol.51
, pp. 546-553
-
-
Ellard, S.1
Bellanné-Chantelot, C.2
Hattersley, A.T.3
-
8
-
-
84879055014
-
Use of HbA1c in the identification of patients with hyperglycaemia caused by a glucokinase mutation: Observational case control studies
-
Steele AM, Wensley KJ, Ellard S, et al. Use of HbA1c in the identification of patients with hyperglycaemia caused by a glucokinase mutation: Observational case control studies. PLoS One 2013;8:e65326
-
(2013)
PLoS One
, vol.8
, pp. e65326
-
-
Steele, A.M.1
Wensley, K.J.2
Ellard, S.3
-
9
-
-
84922569184
-
Zinc transporter 8 autoantibodies: What is their clinical relevance in gestational diabetes?
-
Rudland VL, Pech C, Harding AJ, et al. Zinc transporter 8 autoantibodies: What is their clinical relevance in gestational diabetes? Diabet Med 2015;32:359-366
-
(2015)
Diabet Med
, vol.32
, pp. 359-366
-
-
Rudland, V.L.1
Pech, C.2
Harding, A.J.3
-
10
-
-
70350741368
-
Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia
-
Osbak KK, Colclough K, Saint-Martin C, et al. Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia. Hum Mutat 2009;30:1512-1526
-
(2009)
Hum Mutat
, vol.30
, pp. 1512-1526
-
-
Osbak, K.K.1
Colclough, K.2
Saint-Martin, C.3
-
11
-
-
0030871929
-
Gestational diabetes mellitus and gene mutations which affect insulin secretion
-
Allan CJ, Argyropoulos G, Bowker M, et al. Gestational diabetes mellitus and gene mutations which affect insulin secretion. Diabetes Res Clin Pract 1997;36:135-141
-
(1997)
Diabetes Res Clin Pract
, vol.36
, pp. 135-141
-
-
Allan, C.J.1
Argyropoulos, G.2
Bowker, M.3
-
12
-
-
74549140993
-
Prevalence and trends in obesity among US adults 1999-2008
-
Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010;303:235-241
-
(2010)
JAMA
, vol.303
, pp. 235-241
-
-
Flegal, K.M.1
Carroll, M.D.2
Ogden, C.L.3
Curtin, L.R.4
-
13
-
-
78649322855
-
Maturity-onset diabetes of the young (MODY) how many cases are we missing?
-
Shields BM, Hicks S, ShepherdMH, Colclough K, Hattersley AT, Ellard S.Maturity-onset diabetes of the young (MODY): How many cases are we missing? Diabetologia 2010;53:2504-2508
-
(2010)
Diabetologia
, vol.53
, pp. 2504-2508
-
-
Shields, B.M.1
Hicks, S.2
Shepherd, M.H.3
Colclough, K.4
Hattersley, A.T.5
Ellard, S.6
-
14
-
-
0034851537
-
Glucokinase mutations in a phenotypically selected multiethnic group of women with a history of gestational diabetes
-
Kousta E, Ellard S, Allen LI, et al. Glucokinase mutations in a phenotypically selected multiethnic group of women with a history of gestational diabetes. Diabet Med 2001;18:683-684
-
(2001)
Diabet Med
, vol.18
, pp. 683-684
-
-
Kousta, E.1
Ellard, S.2
Allen, L.I.3
|